The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice

Blood

Volumn 89, Issue 2, 1997, Pages 577-582

  Netea, Mihai G ^a   Kullberg, Bart Jan ^a   Blok, Willem L ^a   Netea, Romana T ^a   Van Der Meer, Jos W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BICARBONATE; CATALASE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; HYPERURICEMIA; INFLAMMATION; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 0031016472     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.2.577     Document Type: Article

References (24)

1. Bodey GP, Buckley M, Sathe YS, Freireich EJ: Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328, 1966
2. Dinarello CA: Role of interleukin-1 and tumor necrosi factor in systemic responses to infection and inflammation, in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1992, p 211
3. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, Van der Meer JWM, Endres S, Lonnemann G, Corsetti J, Chernow B, Wilmore DW, Wolff SM, Burke JF, Dinarello CA: Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 161:79, 1990
4. Marks JD, Marks CB, Luce JM, Montgomery AB, Turner J, Metz CA, Murray JF: Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141:94, 1990
5. Silva AT, Bayston KF, Cohen J: Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-α in experimental gram-negative shock. J Infect Dis 162:421, 1990
6. Tracey CJ, Fong Y, Hesse DG, Manogue KR, Lee T, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662, 1987
7. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA: A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 5:338, 1991
8. Alexander HR, Doherty GM, Buresh C, Venzon DJ, Norton JA: A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice. J Exp Med 173:1029, 1991
9. Lesslauer W, Tabuchi H, Gentz R, Brockhaus M, Schlaeger E, Grau G, Piguet PF, Pontaire P, Vassalli P, Loetscher H: Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 21:2883, 1991
10. Riikonen P, Saarinen UM, Teppo AM, Metsarinne K, Fyhrquist F, Jalanko H: Cytokine and acute-phase reactant levels in serum of children with cancer admitted for fever and neutropenia. J Infect Dis 166:432, 1992
11. Steimetz HT, Herbertz A, Bertram M, Diehl V: Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis. J Infect Dis 171:225, 1995
12. Steinshamn S, Waage A: Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect Immun 60:4003, 1992
13. Netea MG, Blok WL, Kullberg BJ, Bemelmans M, Vogels MTE, Buurman WA, Van der Meer JWM: Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect Dis 171:393, 1995
14. Steinshamn S, Bemelmans MHA, Buurman WA, Waage A: Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: A possible mechanism of enhanced TNF activity. Cytokine 7:50, 1995
15. Di Giovine DS, Malawista SE, Thornton E, Duff GW: Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. J Clin Invest 87:1375, 1991
16. Roberge CJ, de Medicis R, Dayer JM, Rola-Pleszczynski M, Naccache PH, Poubelle PR: Crystal-induced neutrophil activation: V. Differential production of biologically active IL-1 and IL-1 receptor antagonist. J Immunol 152:5485, 1994
17. Van't Wout JW, Linde I, Leijh PCJ, van Furth R: Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction. Inflammation 13:1, 1989
18. Netea MG, Demacker PNM, Kullberg BJ, Boerman OC, Verschueren I, Stalenhoef AFH, Van der Meer JWM: Low-density lipoprotein receptor deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 97:1366, 1996
19. Xun CQ, Thompson JS, Jennings CD, Brown SA, Widmer MB: Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2 incompatible transplanted SCID mice. Blood 83:2360, 1994
20. Marcinkiewicz J, Bryniarski K, Ptak W: Cyclophosphamide uncovers two separate macrophage subpopulations with opposite immunogenic potential and different patterns of monokine production. Cytokine 6:472, 1994
21. Neihorster M, Inoue M, Wendel A: A link between extracellular reactive oxygen and endotoxin-induced release of tumour necrosis factor α in vivo. Biochem Pharmacol 43:1151, 1992
22. Neta R, Oppenheim JJ, Douches SD: Interdependence of the radioprotective effects of human recombinant interleukin-1α, tumor necrosis factor-α, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J Immunol 140:108, 1988
23. Greendyke RM, Sharma K, Gifford FR: Serum cytokine levels in patients with neutropenia. Arch Pathol Lab Med 118:1193, 1994
24. Sisson DS, Dinarello CA: Production of interleukin-1α, interleukin-1β and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood 72:1368, 1988